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Signal peptide peptidase (SPP) assembles with substrates and misfolded
membrane proteins into distinct oligomeric complexes
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SPP (signal peptide peptidase) is an aspartyl intramembrane
cleaving protease, which processes a subset of signal peptides,
and is linked to the quality control of ER (endoplasmic reticulum)
membrane proteins. We analysed SPP interactions with signal
peptidesandothermembraneproteinsbyco-immunoprecipitation
assays. We found that SPP interacts speciﬁcally and tightly
with a large range of newly synthesized membrane proteins,
including signal peptides, preproteins and misfolded membrane
proteins, but not with all co-expressed type II membrane proteins.
Signal peptides are trapped by the catalytically inactive SPP
mutant SPP
D/A. Preproteins and misfolded membrane proteins
interact with both SPP and the SPP
D/A mutant, and are not
substrates for SPP-mediated intramembrane proteolysis. Proteins
interacting with SPP are found in distinct complexes of different
sizes. A signal peptide is mainly trapped in a 200 kDa SPP
complex, whereas a preprotein is predominantly found in a
600 kDa SPP complex. A misfolded membrane protein is
detected in 200, 400 and 600 kDa SPP complexes. We conclude
that SPP not only processes signal peptides, but also collects
preproteinsandmisfoldedmembraneproteinsthataredestinedfor
disposal.
Key words: endoplasmic reticulum quality control, intramem-
brane proteolysis, oligomeric membrane protein complex, signal
peptide peptidase (SPP).
INTRODUCTION
SPP (signal peptide peptidase) is an intramembrane cleaving
protease of the GxGD-type aspartyl protease family [1]. These
proteases are polytopic membrane proteins with their active sites
located in two adjacent transmembrane domains. They promote
peptide bond hydrolysis of transmembrane proteins in the plane
of cellular membranes [2].
SPP is located in the ER (endoplasmic reticulum) membrane,
where it functions in the processing of signal sequence-derived
signal peptides [3]. Signal sequences are N-terminal extensions
of nascent secretory and membrane proteins, and mediate protein
targeting to the ER membrane and insertion into the membrane
[4]. They typically have a tripartite structure consisting of an
N-terminal region, a central hydrophobic h-region, and a C-
terminal region including the cleavage site for signal peptidase
[5]. Following insertion of the nascent polypeptide, signal
peptidase usually cleaves off the signal sequence from the parent
preprotein[6].SPPprocessessomeoftheresultingsignalpeptides
within their membrane-spanning h-region and thereby generates
fragmentsthatareliberatedfromtheERmembrane[3,7].Someof
themactasbioactivepeptides,forexamplethosederivedfromthe
signal sequences of MHC class I molecules, the hepatitis C virus
polyprotein, the HIV-1 Env glycoprotein or pPrl (preprolactin)
[8,9]. In these cases, SPP-mediated processing affects diverse
pathways such as immune surveillance, virus maturation or
cellular signalling. All SPP substrates identiﬁed to date are signal
peptides [10,11]. They span the ER membrane in a type II
topology, exposing the N-terminus to the cytosol and the C-
terminus to the exoplasm [12]. It is therefore assumed that SPP
processes only type II oriented peptides, whereas type I oriented
peptides are processed by other intramembrane proteases [11].
Signal peptides need to be released from their parent preproteins
by signal peptidase cleavage to become SPP substrates, a process
called ectodomain shedding [10,13].
Besides processing signal peptides, SPP may also contribute
to protein quality control at the ER membrane. Such a function
was proposed from the identiﬁcation of SPP as a cross-linking
partner of misfolded variants of the polytopic membrane protein
opsin [14]. Furthermore, SPP is implicated in the US2-dependent
dislocation of MHC class I heavy chains from the ER membrane.
US2 is a HCMV (human cytomegalovirus)-encoded protein and
forms a complex with SPP. Both proteins are required for the
dislocation of full-length MHC class I heavy chains to the cytosol
[15].
SPP can be isolated as a monomer and as an SDS-stable
dimer [16,17]. For proteolytic processing, SPP does not require
additional cofactors, since puriﬁed recombinant SPP is able to
process a substrate [18]. This is in contrast with presenilin-
dependent intramembrane processing. The aspartyl protease
presenilin is the catalytic core unit of the γ-secretase complex
consisting of at least four subunits. All components are essential
for complex assembly, substrate selection and protease function
[19].
Considering the processing of signal peptides and the
proposed role of SPP in the dislocation of other membrane
Abbreviations used: BN-PAGE, blue native PAGE; 2D-BN-SDS/PAGE, two-dimensional blue native SDS/PAGE; DDM, n-dodecyl-β-D-maltoside; DTT,
dithiothreitol; ER,endoplasmicreticulum;ERAD, ER-associateddegradation;HA, haemagglutinin;HCMV, humancytomegalovirus;HEK, humanembryonic
kidney; Ii, MHC class II-associated invariant chain; pPrl, preprolactin; RAMP4, ribosome-associated membrane protein 4; RAMP4op, RAMP4 with an opsin
tag encoding a glycosylation site appended to its C-terminus; SPPrl, signal peptide of preprolactin; SPFPrl, signal peptide fragment of preprolactin; SPP,
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proteins [14,15], the question arises of how SPP selects its
substrates for intramembrane processing or ER membrane
dislocationanddegradation.Inthepresentstudy,wecharacterized
SPP interactions with potential substrates and other proteins
bearing a type II oriented transmembrane domain by co-
immunoprecipitation. We found that SPP speciﬁcally interacts
with a large range of newly synthesized membrane proteins
including a signal peptide, a preprotein and a misfolded polytopic
membrane protein. Using BN-PAGE (blue native PAGE), we
identiﬁed distinct SPP complexes and discovered that a substrate
and a preprotein, as well as a misfolded membrane protein,
assemble with SPP complexes of different sizes.
EXPERIMENTAL
Plasmids
SPP–myc and SPP
D/A (SPP-D265A)–myc were generated
by PCR using the primers 5
 -CCCGGGTCATTTCTCTT-
TCTTCAAGTCCTCTTCAGAAATGAGCTTTTGCTCCTCC-
AGCCCCTTCGATGC-3
  and 5
 -ATTTAGGTGACACTATAG-3
 
with pSV-Sport1-SPP and pSV-Sport1-SPP-D265A [17] as
templates. Thereby, a myc tag is introduced N-terminal to the
KKEK (Lys-Lys-Glu-Lys) ER retention signal. PCR products
were cloned into pRK5rs. pRK5rs and pRK5rs-pPrl have
been described previously [20]. Starting with pRK5rs-pPrl,
pRK5rs-pPrl
PP29 was generated by site-directed mutagenesis
using the primers 5
 -CTACTCTTGTGCCAGGGTCCGCC-
TTCCACCCCCGTCTGTCCC-3
  and 5
 -GGGACAGACGGG-
GGTGGAAGGCGGACCCTGGCACAAGAGTAG-3
 .C - t e r m i -
nal HA (haemagglutinin)-tagged forms of pPrl and pPrl
PP29
were generated by PCR on pRK5rs-pPrl and pRK5rs-pPrl
PP29
using primers 5
 -CGCTCGAGTTAAGCGTAATCTGGAAC-
ATCGTATGGGTAGCAGTTGTTGTTGTAGATGATTCTGC-3
 
and 5
 -CGATTGAATTCCCCGGGGATCCTCTAGAGTCGAC-
CCAGCTTG-3
  and cloned into pRK5rs. pcDNA3.1-RAMP4op
is derived from pGEM4Z-RAMP4/3
 UTR/op [21] by PCR using
theprimers5
 -GAATTCTCCACCATGGTCGCCAAGCAGAGG-
3
  and 5
 -GAATTCAAGCTTCAGCCCGTCTTGTTGG-3
 .
pSV51-Ii is described in [22]. pRK5rs-OP91H* was generated
by PCR on pZEO-OP91H+(cys56) (compare with [14])
using the primers 5
 -TAATACGACTCACTATAGGG-3
  and
5
 -TAGAAGGCACAGTCGAGG-3
  and cloning into pRK5rs.
Antibodies
Anti-myc and anti-opsin antibodies were prepared from 9E10 or
R2-15 hybridoma cell supernatants respectively, using standard
procedures. SPP-speciﬁc rabbit antibodies (C18) recognize an
epitope in amino acids 353–377 of human SPP [23]. Anti-
HA and anti-α-tubulin antibodies were purchased from Covance
and Sigma ImmunoChemicals respectively. Anti-pPrl, anti-SP
Prl
(signalpeptideofpPrl)[24],anti-invariantchainandanti-RAMP4
(ribosome-associated membrane protein 4) antibodies [22] have
been described previously. Anti-(mouse IgG) and anti-(rabbit
IgG) antibodies conjugated with horseradish peroxidase were
obtained from Sigma.
Cell culture and transient transfection
HEK (human embryonic kidney) -293 cells (European Collection
of Animal Cell Cultures, 85120602) were grown in Dulbecco’s
modiﬁed Eagle’s medium/Ham’s F12 (Invitrogen) supplemented
with 10% (v/v) fetal bovine serum and 2 mM L-glutamine. Cells
were regularly controlled for the absence of mycoplasma using
standard PCR. Cells (3×10
5) were seeded in six-well slots,
used for calcium phosphate transfection as described in [20], and
harvested 44 h later.
Metabolic labelling and immunoprecipitation
Cells were depleted and metabolically labelled essentially as
described in [20] and in the Figure legends. They were lysed
in Triton X-100-containing lysis buffer [50 mM Hepes (pH 7.5),
150 mM NaCl, 1% (v/v) Triton X-100, 10% (v/v) glycerol,
1.5 mM MgCl2, 1 mM EGTA, 1 mM PMSF and Complete
TM
protease inhibitor cocktail (Roche)] or in digitonin-containing
lysis buffer [1% (w/v) digitonin, 20 mM Tris/HCl (pH 7.5),
1.5 mM MgCl2,1m ME G T A ,5 0m MN a C l ,1 0% (v/v) glycerol
and protease inhibitors as described above]. Non-solubilized
material was removed by centrifugation at 16000 g for 10 min at
4◦C. When indicated, 1/10 of the lysate was mixed directly with
SDS-sample buffer [for Tris/Tricine gels: 4% (w/v) SDS, 75 mM
Tris/HCl (pH 6.8), 12% (v/v) glycerol, 0.01% Serva Blue G
and 50 mM DTT (dithiothreitol); for Tris/glycine gels: 2% (w/v)
SDS, 50 mM Tris/HCl (pH 6.8), 10% (v/v) glycerol, 0.01%
Bromophenol Blue and 50 mM DTT]. For immunoprecipitation,
thecelllysatewasdilutedinHNTGlow-saltbuffer[20 mMHepes
(pH 7.5), 150 mM NaCl, 0.1% Triton X-100 and 10% (v/v)
glycerol] or in TNDG buffer [20 mM Tris/HCl (pH 7.5), 50 mM
NaCl, 0.1% digitonin and 10% (v/v) glycerol]. Antibodies and
either Protein A–Sepharose or Protein G–Sepharose beads (GE
Healthcare) were added for 3 h at 4◦C. Beads were washed ﬁve
times with HNTG high-salt buffer (HNTG buffer with 500 mM
NaCl instead of 150 mM) or with TNDG buffer. Samples were
heated at 65◦C for 10 min and separated by Tris/Tricine or
Tris/glycine SDS/PAGE using the methods of Sch¨ agger and
von Jagow [25] and Laemmli [26] respectively. Dried gels were
analysed by PhosphoImaging (Fuji BAS 1500).
Western blotting
Cellswerelysedandproteinsseparatedasdescribedabove.Then,
proteins were transferred on to membranes in a semi-dry blotting
unit. Blocking and ﬁrst antibody incubation was done in 0.25%
gelatin in TBS-T [Tris-buffered saline with Triton X-100: 50 mM
Tris/HCl(pH 7.5),150 mMNaCl,5 mMEDTAand0.05%Triton
X-100], washing and secondary antibody incubation was carried
out in TBS-T. For immunodetection, BM chemiluminescence
blotting substrate (POD, Roche Applied Science) was used. In
thecaseofre-probingthemembraneswithanti-tubulinantibodies,
the membranes were stripped with 62.5 mM Tris/HCl (pH 6.7),
2% (w/v) SDS and freshly added 0.5% 2-mercaptoethanol for
30 min at 50◦C.
BN-PAGE
Cells were lysed in BN-lysis buffer (digitonin-containing lysis
buffer, as above, but containing 1% of detergents as indicated
in the Figure legends). Non-solubilized material was removed by
centrifugation at 16000 g for 10 min at 4◦C. A 1/40 volume of
BN-sample buffer [500 mM 6-aminohexanoic acid, 100 mM Bis-
Tris (pH 7) and 5% (w/v) Coomassie Blue G250] was added to
the lysate before subjection to BN-PAGE [27]. Samples were
loaded on to 5–9%, 6–13% or 6–16% gradient gels [with
67 mM 6-aminohexanoic acid and 50 mM Bis-Tris (pH 7)] and
run at 4◦C for 1 h at 15 mA with cathode buffer B [50 mM
Tricine (pH 7), 15 mM Bis-Tris and 0.02% Coomassie Blue
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G250]. Then, the cathode buffer was exchanged for cathode
buffer B/10 (buffer B but containing only 0.002% Coomassie
Blue G250) and gels were run at 100 V [anode buffer: 50 mM
Bis-Tris (pH 7)]. As molecular markers, the high-molecular-
mass kit for native electrophoresis (GE Healthcare) was used.
For Western blotting, BN gels were soaked in Tris/glycine-
SDS-electrophoresis buffer [26], then in BN-transfer buffer
[25 mM Tris, 150 mM glycine, 0.02% SDS and 20% (v/v)
methanol] and proteins were transferred via semi-dry blotting
on to PVDF membranes (Millipore). Membranes were destained
with methanol and immunodetection was performed as described
above.
2D-BN-SDS/PAGE
Lanes from the BN gel were excised, incubated in SDS-sample
buffer for 30 min and analysed using SDS/PAGE, and the
following Western blots were performed according to standard
protocols as described above.
Afﬁnity puriﬁcation of SPP complexes and MS
TopurifySPP
D/A–myccontainingcomplexes,anti-mycantibodies
were coupled to CNBr–Sepharose beads (GE Healthcare) ac-
cording to the manufacturer’s instructions. Cells transfected with
pRK5rs-SPP
D/A-myc and pRK5rs-Prl or mock-transfected cells
were lysed in BN-lysis buffer containing 1% (w/v) digitonin.
Beadswereequilibratedinthesamebuffer,mixedwiththelysates
and incubated for 16 h at 4◦C. Non-bound material was removed
by washing the beads four times with BN-lysis buffer, and bound
material was eluted by competition with synthetic myc peptide
(Sigma) for 2 h at 4◦C. Fractions of each step were mixed with
BN-samplebufferandsubjectedtoBN-PAGE.Thegelwassilver-
stained [28]. For LC–MS/MS (liquid chromatography–tandem
MS) analysis, the band containing the 200 kDa complex was
excised from the gel together with a reference region from a
lysate of mock-transfected cells.
Densitometric analyses of protein bands
Densitometric analysis was carried out with ImageJ. Each signal,
represented by a deﬁned area, was corrected for background
by subtracting a signal from an identical area within the same
lane. For statistical analyses, relative amounts were calculated,
i.e. signals from each time point were adjusted to 100%.
Relative amounts are given as mean+ −S.D. percentages for three
independent experiments.
RESULTS
The SPP substrate SPPrl tightly interacts with SPPD/A
To characterize the interaction of SPP with potential substrates
and with other integral membrane proteins, we employed co-
immunoprecipitation of metabolically labelled proteins. As a
model substrate, we used the pPrl-derived signal peptide, SP
Prl
(Figure 1B), which was shown previously to be processed by SPP
in an in vitro translation/translocation system [3,7]. To generate
SP
Prl in cells, we overexpressed pPrl. Additionally, we expressed
myc-tagged SPP or the catalytically inactive SPP mutant SPP
D/A,
which is known to lack proteolytic activity (Figure 1A [1,29]).
HEK-293 cells transiently expressing pPrl alone or together
with either SPP or SPP
D/A were metabolically labelled and
then lysed either directly or chased for 1 h. To detect SP
Prl
by immunoprecipitation, we used an antibody recognizing an
epitope in the N-terminal region of the pPrl signal sequence (anti-
SP
Prl), which had been characterized previously [24]. Aliquots of
total lysates (Figure 1C, lanes 1–8) and the immunoprecipitated
proteins (Figure 1C, lanes 9–16) were separated by Tris/Tricine
SDS/PAGE, which allows a high resolution of small proteins.
Finally, labelled proteins were visualized by autoradiography.
When pPrl alone was expressed, the 3 kDa SP
Prl and its smaller
fragment, SPF
Prl, were detected after pulse labelling in the
immunoprecipitate (Figure 1C, lane 10), but not after 1 h of chase
(Figure 1C, lane 14). This indicates that SP
Prl in cells is processed
and that the resulting fragment SPF
Prl has a rather short half-life.
After co-expression with SPP, no SP
Prl and only small amounts
of SPF
Prl were found (Figure 1C, lanes 11 and 15), suggesting
that overexpressed SPP increases the rate of processing and leads
to a rapid degradation of SPF
Prl. When SPP
D/A was co-expressed
with pPrl, SP
Prl accumulated (Figure 1C, lanes 4 and 12) and was
stabilized over time (Figure 1C, lanes 8 and 16). Thus SPP
D/A can
efﬁcientlypreventSP
Prl processinganddegradation.Theanti-SP
Prl
antibody did not efﬁciently immunoprecipitate SP
Prl under these
nativeconditions(Figure1C,lanes12and16comparedwithlanes
4 and 8). This may indicate that, under these conditions, SP
Prl is
not accessible for the antibody.
To see whether SP
Prl interacts with SPP
D/A, we performed
co-immunoprecipitation using the anti-myc antibody. This
antibody recognizes myc-tagged SPP and SPP
D/A, which are
detected in the gel as monomers and dimers (Figure 1C,
lanes 17–24). Similar amounts of SPP and SPP
D/A were
immunoprecipitated (Figure 1C, lanes 19, 20, 23 and 24) and
could be detected after Western blotting (see Supplementary Fig-
ure S1 at http://www.BiochemJ.org/bj/427/bj4270523add.htm),
demonstrating similar expression levels of both proteins. SP
Prl
was efﬁciently co-immunoprecipitated with SPP
D/A (Figure 1,
lanes 20 and 24, and see Supplementary Figure S2 at
http://www.BiochemJ.org/bj/427/bj4270523add.htm).
In order to test whether SP
Prl also interacts with an SPP-
like (SPPL) protease, pPrl was co-expressed with the ER-
localizedSPPL3[30]anditscatalyticallyinactivemutantSPPL3-
D271A, here termed SPPL3
D/A (see Supplementary Figure
S3 at http://www.BiochemJ.org/bj/427/bj4270523add.htm). No
SP
Prl accumulated in the presence of SPPL3
D/A and no co-
immunoprecipitation of SP
Prl and SPPL3
D/A was detected.
This suggests that SPP
D/A cannot be functionally replaced by
SPPL3
D/A. Taken together, these results show that SP
Prl is
processedbySPPincellsandthatthecatalyticallyinactivemutant
SPP
D/A is an efﬁcient dominant-negative mutant that interacts
tightly with SP
Prl.
pPrl interacts with SPP and is no substrate for SPP-mediated
processing
In addition to SP
Prl, we observed the speciﬁc co-
immunoprecipitation of a 25 kDa protein with SPP and SPP
D/A
(Figure 1C, right-hand panel and Supplementary Figure S2). As
this protein could be immunoprecipitated with an anti-prolactin
antibody[24],butisapprox.3 kDalargerthanprolactin,itmustbe
preprolactin(Figure1D).WhenpPrlalonewasexpressed,mainly
prolactin of approx. 22 kDa was immunoprecipitated and only a
small amount of pPrl accumulated (Figure 1D, lanes 2 and 8),
indicating that pPrl is efﬁciently inserted into ER membranes
where its signal sequence is cleaved off. In contrast, higher
amounts of pPrl accumulated in the presence of co-expressed
SPP or SPP
D/A (Figure 1D, lanes 5, 6, 11 and 12) and were
co-immunoprecipitated (Figure 1D, lanes 17, 18, 23 and 24).
This suggests that overexpression of SPP increases the amount
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Figure 1 The effect of SPP and SPPD/A on SPPrl and pPrl processing and binding
(A) Schematic representation of SPP in the ER membrane with amino acids of the active-site motif in one-letter code. The D→A mutation in SPPD/A and the position of the myc tag are indicated.
KKEK, ER retrieval motif. Fork-like structures indicate N-linked glycosylation sites. (B) Outline and amino acid sequence of the signal sequence of pPrl with its N-terminal (n), hydrophobic
(h)andC-terminal(c)region.Thecleavagesiteforsignalpeptidase(SPase)isindicated,andtheh-regionisunderlined.(C)SP Prl istrappedbythedominant-negativemutantSPPD/A.HEK-293cells
transiently expressing pPrl, SPP–myc or SPPD/A–myc were metabolically pulse labelled for 30min and chased for 1 h where indicated. Cells were lysed in the presence of 1% Triton X-100. A 1/10
sample of the total lysate was analysed directly using SDS/PAGE and the rest was used for immunoprecipitation (IP) using either anti-SPPrl antibodies or anti-myc antibodies to identify myc-tagged
SPP/SPPD/A.SamplesweresubjectedtoTris/TricineSDS/PAGEandlabelledproteinswerevisualizedbyautoradiography.v,emptyvectorcontrol;SPFPrl,signalpeptidefragmentofSP Prl;Prl,mature
prolactin. SPP–myc dimer (di) and monomer (mo) are indicated. Note that the monomer is detected as a double-band, representing non-glycosylated and glycosylated SPP (results not shown).
Molecular masses are indicated in kDa. (D) pPrl co-immunoprecipitates with SPP and SPPD/A. HEK-293 cells were transfected and pulse–chase labelled as described in (C). To detect pPrl and
mature prolactin (Prl), anti-Prl antibodies were used for immunoprecipitation (IP). Anti-myc antibodies were used for the identiﬁcation of myc-tagged SPP/SPPD/A and for co-immunoprecipitation.
Proteins were separated by Tris/glycine SDS/PAGE and visualized as described in (C). Molecular masses are indicated in kDa.
of the preprotein pPrl at the expense of processed prolactin. pPrl
interacts with SPP
D/A and catalytically active SPP, accumulates
and is not processed with time. This strongly indicates that it is
not a substrate for SPP. This is consistent with the earlier ﬁnding
that cleavage by signal peptidase is required for intramembrane
proteolysis by SPP [10].
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SPP does not interact with the type II oriented membrane proteins
Ii (MHC class II-associated invariant chain) and RAMP4
Signalpeptides,liketheirpreproteins,spantheERmembraneina
type II orientation, exposingthe N-terminus towards the cytosolic
side of the membrane [12]. In order to investigate whether other
type II oriented membrane proteins that comprise non-cleaved
signal sequences also interact with SPP or SPP
D/A,w et e s t e dI i
andRAMP4.Iiisasignal-anchorglycoproteinwithanN-terminal
transmembrane domain [31], whereas RAMP4 is a tail-anchored
membrane protein, which is inserted into the ER membrane via
its C-terminal transmembrane domain [21,32]. To detect RAMP4
membrane insertion, an opsin tag encoding a glycosylation site
was appended to its C-terminus (RAMP4op) [21] (Figure 2A).
In transfected cells, Ii was immunoprecipitated mainly as a
bi-glycosylated protein of 33 kDa (Figure 2B, lane 2). Similar
amounts of Ii were detected upon co-expression with SPP
or SPP
D/A, but Ii was not co-immunoprecipitated with SPP or
SPP
D/A (Figure 2B, lanes 11 and 12). As no smaller forms of Ii
accumulated in the presence of SPP or SPP
D/A, this indicates that
Ii is neither an SPP substrate nor a binding partner (Figure 2B,
lanes 5 and 6).
RAMP4op was immunoprecipitated as a 12 kDa glycoprotein
as characterized previously [21] (Figure 2C, lane 2). In addition,
endogenous RAMP4 of 8 kDa was immunoprecipitated by the
anti-RAMP4 antibody (compare lanes 1 and 2 in Figure 2C).
The co-expression of SPP and SPP
D/A did not affect the
amount of either RAMP4op or endogenous RAMP4. No co-
immunoprecipitation of RAMP4op with overexpressed SPP or
SPP
D/A was found (Figure 2C, lanes 11 and 12). Together, these
data indicate that Ii and RAMP4 neither are SPP substrates
nor interact with co-expressed SPPs. Furthermore, we conclude
that not all type II oriented membrane proteins interact with
SPP/SPP
D/A.
SPP interacts with misfolded opsin
Previously, Crawshaw et al. [14] have shown that SPP can
be cross-linked to a misassembled transmembrane domain of
a truncated mutant of polytopic opsin. This protein–protein
interaction could be prevented by addition of an SPP inhibitor
[14]. In the present study, we characterized this interaction in
our cell-based assay using co-immunoprecipitation. We used
OP91H*,atruncatedopsinmutantthatspansthemembranetwice
(type I and type II oriented transmembrane domains) and can be
bi-glycosylated in the N-terminal region [14] (Figure 3A and
Figure 3B, lanes 2–4).
OP91H* was immunoprecipitated in its non-, mono- and
bi-glycosylated forms after pulse labelling as characterized
previously [14] (Figure 3B, lane 2). Similar amounts of OP91H*
were immunoprecipitated upon co-expression with SPP or
SPP
D/A. Additionally, SPP and SPP
D/A co-immunoprecipitated
withOP91H*(Figure3B,lanes3and4).Employingtheanti-myc
antibody for immunoprecipitation revealed that a small portion of
OP91H* was non-speciﬁcally immunoprecipitated in the absence
of myc-tagged SPP (Figure 3B, lane 6). However, increased
amounts OP91H* speciﬁcally co-immunoprecipitated with co-
expressed SPP and SPP
D/A (Figure 3B, lanes 7 and 8). Taken
together, these data indicate that both SPP and SPP
D/A interact
tightly with a newly synthesized misfolded membrane protein.
SPP impedes the degradation of misfolded opsin
Truncated and misfolded opsin mutants are retained in the
ER membrane where they do not assemble correctly, but can
Figure 2 SPP does not associate with the type II membrane proteins Ii and
RAMP4op
(A) Membrane disposition of a signal peptide (SPPrl), Ii and RAMP4op. Fork-like structures
indicate N-linked glycosylation sites. (B and C)I i( B) and RAMP4op (C) were transiently
expressed alone or together with SPP–myc or SPPD/A–myc, pulse labelled for 30min, and
proteins immunoprecipitated (IP) with anti-Ii (B), anti-RAMP4 (C) or anti-myc antibodies
(B and C). Proteins were separated by Tris/glycine SDS/PAGE (B)o rT r i s / T r i c i n eS D S / P A G E
(C) and visualized by autoradiography. v, empty vector control; RAMP4, endogenous RAMP4;
RAMP4op, non-glycosylated RAMP4op; RAMP4op-g, glycosylated RAMP4op. SPP dimer (di)
and monomer (mo) are indicated. Molecular masses are indicated in kDa.
aggregate or undergo ERAD (ER-associated degradation)
[33,34]. To test whether co-expression of SPP affects the
degradationofOP91H*,wepulse–chaselabelledcellsexpressing
either OP91H* alone or together with SPP or SPP
D/A.
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Figure 3 SPP interacts with misfolded opsin
(A) Membrane disposition of OP91H* in comparison with a signal peptide (SPPrl). Fork-like
structures indicate N-linked glycosylation sites. (B) OP91H* co-immunoprecipitates with
SPP and SPPD/A. HEK-293 cells transiently expressing OP91H*, SPP–myc or SPPD/A–myc
were pulse labelled for 30min, lysed with 1% digitonin and immunoprecipitated (IP) with
anti-opsin antibodies (lanes 1–4), or anti-myc antibodies (lanes 5–8). Proteins were separated
by Tris/glycine SDS/PAGE and visualized by autoradiography. v, empty vector control. -1g and
-2gindicatemono-andbi-glycosylatedopsinformsrespectively.SPPdimer(di)andmonomer
(mo) are indicated. Molecular masses are indicated in kDa.
OP91H* was substantially degraded after 6 h, when expressed
alone (Figure 4A, lanes 1–4 and quantiﬁcation in Figure 4B).
In contrast, the co-expression of either SPP or SPP
D/A resulted
in a longer half-life of OP91H*, indicating that its degradation
was signiﬁcantly impeded (Figure 4A, lanes 5–6 and 9–12,
and quantiﬁcations in Figure 4B). Accumulation was found
in particular for the bi-glycosylated OP91H*, suggesting that
SPP-bound OP91H* was still competent for glycosylation. The
stabilizing effect of co-expressed SPP/SPP
D/A on OP91H* could
also be conﬁrmed under steady-state conditions as depicted by
the Western blot in Figure 4(C). Together, these results show
that the misfolded membrane protein is stabilized in the presence
ofhighSPPamounts.Sinceco-expressionofbothSPPandSPP
D/A
leads to similar observations, we conclude that the stabilization is
independent of the catalytic SPP activity.
SPP is found in distinct high-molecular-mass complexes
Our co-immunoprecipitation data revealed that SPP interacts
with a range of membrane proteins, including substrates as
well as preproteins and misfolded opsins that are not SPP
substrates. In order to characterize further the SPP complexes,
we analysed them using BN-PAGE. First, we tested whether
SPP, which has been characterized under denaturing conditions
as a monomer of 40 kDa and as an SDS-stable dimer of 90 kDa
[16] (Figure 5A) is detectable under native conditions in higher-
molecular-mass complexes. Mock-transfected cells expressing
endogenous SPP and transfected cells expressing SPP–myc were
solubilized by three different detergents [1% digitonin, 1%
Triton X-100, and 1% DDM (n-dodecyl-β-D-maltoside)], and
proteins were separated by BN-PAGE (Figure 5B). Using an
SPP-speciﬁc antibody we detected endogenous (Figure 5B, lanes
1, 3 and 6) and overexpressed (Figure 5B, lanes 2, 4 and 6)
SPP complexes after Western blotting. Both migrated as a major
complex of approx. 200 kDa (C200). Additionally, complexes
of approx. 400 kDa (C400) and 600 kDa (C600) were detected.
Endogenous SPP was detected in one further complex of approx.
250 kDa.Allofthesecomplexesweredetectedaftersolubilization
with the three detergents, indicating that they are rather
stable.
A signal peptide is trapped in a 200 kDa SPP complex
Since SP
Prl accumulates in the presence of SPP
D/A and
can be identiﬁed by Western blotting (Figure 6A, lane 4),
we next used BN-PAGE to identify SP
Prl/SPP
D/A complexes.
Upon Western blotting, the anti-SP
Prl antibody recognized its
epitope in a 200 kDa complex, when pPrl was co-expressed
with SPP
D/A (Figure 6B, lanes 1–4). SPP
D/A complexes were
identiﬁed using the anti-myc antibody, which recognized the
above-described complexes C200, C400 and C600 (Figure 6B,
lane 5). The 200 kDa SP
Prl complex co-migrates with the
SPP
D/A-C200, suggesting that SP
Prl is trapped in this SPP
complex. SP
Prl could also be detected in this complex, when
proteins were solubilized in the presence of Triton X-100 or
DDM, indicating that the SP
Prl/SPP
D/A-C200 is stable under
different detergent conditions (see Supplementary Figure S4 at
http://www.BiochemJ.org/bj/427/bj4270523add.htm).
To identify the protein components of SP
Prl/SPP
D/A-C200,
we afﬁnity-puriﬁed SPP
D/A complexes on anti-myc antibodies.
Figure 6(C) shows the puriﬁcation proﬁle and elution of the
three SPP complexes on a silver-stained blue native gel and
after Western blotting (lanes 1–8). SP
Prl could be identiﬁed as a
componentofpuriﬁedSPP
D/A-C200(Figure6C,lane9).Next,MS
wasusedtoidentifypolypeptideswithinthethreeSPPcomplexes.
In the C200 complex, three different peptide sequences derived
from SPP were obtained. Other peptide sequences were non-
speciﬁcally found in the SPP complexes since they were also
found in samples obtained after a mock-puriﬁcation. Together,
these data suggest that SPP is the main, possibly the sole,
constituent of the C200 complex. We also attempted to identify
the protein constituents of the SPP-C400 and -C600 complexes.
However, no peptide sequences were obtained by MS analysis,
probably due to the small amounts.
pPrl is found in a 600 kDa SPP complex
In addition to SP
Prl that is trapped by SPP
D/A, pPrl interacts tightly
with SPP
D/A and SPP (compare with Figure 1). Therefore we also
identiﬁed pPrl/SPP complexes using BN-PAGE. Since only small
amountsofpPrlaccumulatedincellswhenpPrlwasco-expressed
with SPP or SPP
D/A (Figure 7B, lanes 1–4), we generated the pPrl
mutant pPrl
PP29, which is not cleaved by signal peptidase and
thus leads to the accumulation of pPrl [10,13] (Figure 7A, and
Figure 7B, lanes 5–7).
After BN-PAGE and Western blotting, the anti-SP
Prl antibody
recognized its epitope in a 200 kDa complex when wild-type
pPrl was co-expressed with SPP
D/A (Figure 7B, lanes 8–14).
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Figure 4 SPP impedes the degradation of misfolded opsin
(A) Pulse-chase analysis of OP91H*. HEK-293 cells transiently expressing OP91H* in the absence or presence of SPP–myc or SPPD/A–myc were pulse labelled for 10min and chased for the
indicated times. Digitonin lysates were used for immunoprecipitation (IP) with the anti-opsin antibody. -1g and -2g indicate mono- and bi-glycosylated opsin forms respectively. SPP dimer (di) and
monomer (mo) are indicated. Molecular masses are indicated in kDa. (B) Quantiﬁcation of OP91H* accumulation. Three independent experiments as shown in (A) were used for the quantiﬁcation of
OP91H* accumulation in the absence (left-hand panel) or in presence of SPP–myc (middle panel) or SPPD/A–myc (right-hand panel) respectively. The OP91H* amount after the pulse (0h chase)
was set to 100%. Results are relative means+ −S.D. for three independent experiments. (C) Western blotting (WB) shows OP91H* accumulation in the presence of SPP. HEK-293 cells transiently
expressing OP91H* and SPP–myc or SPPD/A–myc as indicated were lysed with 1% digitonin, and aliquots were separated by Tris/glycine SDS/PAGE. OP91H* and SPP/SPPD/A–myc proteins were
identiﬁed using Western blotting using anti-opsin (left-hand panel) and anti-myc antibodies (right-hand panel) respectively. Membranes were stripped and re-probed with anti-tubulin antibodies as
a loading control (lower panels). -1g and -2g indicate mono- and bi-glycosylated opsin forms respectively. SPP dimer (di) and monomer (mo) are indicated. Molecular masses are indicated in kDa.
However, we could not detect pPrl
PP29 complexes after BN-
PAGE and Western blotting. Most likely, the corresponding
epitope was not available after blotting from the blue native gel.
To circumvent this problem, we separated the complexes in a
second dimension using SDS/PAGE, termed 2D-BN-SDS/PAGE
(Figure 7C). When HA-tagged pPrl
PP29 was co-expressed with
SPP
D/A, it was detected as a 30 kDa protein after the second-
dimension SDS/PAGE (Figure 7C, bottom panel). SPP migrated
as 90 kDa dimers (Figure 7C, middle panel), indicating an even-
numbered stoichiometry of SPP in the complexes. pPrl
PP29 co-
migrates with the large SPP-C600 complex, strongly indicating
that it is present in this complex. As a control, a similar
analysis applying wild-type pPrl showed that mature prolactin
is not incorporated into higher-molecular-mass complexes, but
migratedinarangebelow60 kDaaccordingtotheﬁrst-dimension
BN-PAGE (results not shown). We conclude that SP
Prl and
its preprotein assemble into SPP complexes of different sizes.
While SP
Prl is trapped in C200, the preprotein predominantly
accumulates in C600.
Misfolded opsin accumulates in three distinct SPP complexes
As misfolded opsin OP91H* also interacts with SPP and SPP
D/A
(Figure 3), we next analysed OP91H*–SPP complexes by BN-
PAGE. Lysates of cells expressing OP91H* alone or together
with SPP or SPP
D/A were analysed by BN-PAGE and Western
blotting (Figure 8A). Upon co-expression with SPP and SPP
D/A,
OP91H* is found to co-localize with the three SPP complexes
C200, C400 and C600 (Figure 8A, compare lanes 3 and 4 with
lanes 6 and 7). Very low amounts of the OP91H*–SPP complexes
were detected in lysates from cells expressing OP91H* alone
(Figure 8A, lane 2 and compare with Supplementary Figure S5
at http://www.BiochemJ.org/bj/427/bj4270523add.htm for long
exposure). This again corroborates the strong stabilizing effect
of SPP on OP91H* as found after pulse–chase labelling and
immunoprecipitation (compare with Figure 4).
OP91H*hastwoN-glycosylationsitesandisdetectedasanon-,
mono- or bi-glycosylated form after SDS/PAGE (Figures 3 and
4). In order to test whether the glycosylation status determines
the assembly into one particular SPP complex, we analysed
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Figure 5 Endogenous and overexpressed SPP is found in distinct high-
molecular-mass complexes after BN-PAGE
(A) After SDS/PAGE, SPP is detected as a monomer and SDS-stable dimer. HEK-293 cells
transiently expressing SPP–myc were lysed with digitonin (Dig). Proteins were separated by
SDS/PAGE, and SPP monomers (mo) and dimers (di) were identiﬁed by Western blotting
(WB) using anti-myc antibodies. v, empty vector control. (B) Detection of SPP complexes after
BN-PAGE. HEK-293 cells transiently expressing SPP–myc or transfected with an empty vector
(v), were lysed with digitonin (Dig), Triton X-100 (Tx) or DDM. Total lysates were subjected
to BN-PAGE (5–9%). Endogenous and overexpressed SPP complexes of 200kDa (C200),
400kDa (C400) and 600kDa (C600) were then identiﬁed by Western blotting (WB) using an
SPP-speciﬁc antibody. Molecular masses are indicated in kDa.
OP91H*–SPP and OP91H*–SPP
D/A complexes using 2D-BN-
SDS/PAGE (Figures 8B–8D). When OP91H* was expressed
alone, glycosylated and non-glycosylated forms of OP91H*
were mainly detected in high-molecular-mass complexes of
approx.600 kDaaftersecond-dimensionSDS/PAGE(Figure8B).
When co-expressed with SPP or SPP
D/A, glycosylated and non-
glycosylated OP91H* forms were detected to similar extents
in the 200, 400 and 600 kDa complexes (Figures 8C and
8D), indicating that the glycosylation status does not determine
OP91H* assembly into one particular SPP complex.
DISCUSSION
SPP interacts tightly with a signal peptide and a range of
membrane proteins
We have investigated SPP interactions with a set of membrane
proteins with type II oriented transmembrane regions. The
pPrl-derived signal peptide SP
Prl is an SPP substrate and
interacts tightly with the catalytically inactive SPP mutant
SPP
D/A. The parent preprotein, pPrl, as well as the misfolded
opsin OP91H* also interact with SPP
D/A and furthermore with
catalytically active SPP. Since pPrl and OP91H* accumulate
in the presence of catalytically active SPP and no smaller
processing fragments were detected, these proteins are not
substrates for SPP-mediated processing. They bind to SPP, but
are not processed and are in the following section termed SPP
client proteins. No interaction of the type II membrane proteins
Ii and RAMP4op with SPP was detected. We conclude that SPP
interacts with a range of membrane proteins that is not restricted
to substrates, but it does not interact with all type II membrane
proteins.
Figure 6 Characterization of SPPrl/SPP complexes
(A) Steady-state accumulation of SPPrl in the presence of SPPD/A. HEK-293 cells transiently
expressing pPrl alone or together with SPP–myc or SPPD/A–myc were lysed in 1% Triton
X-100 buffer, and proteins were separated by Tris/Tricine SDS/PAGE. SPPrl was identiﬁed upon
SPPD/A–mycco-expressionbyWesternblotting(WB)usingtheanti-SPPrl antibody.(B)SP Prl is
trappedina200kDaSPPcomplex.DigitoninlysatesofHEK-293cellsexpressingpPrl,SPP–myc
orSPPD/A–mycasindicatedwereseparatedbyBN-PAGE(6–13%).SPPrl-containingcomplexes
were identiﬁed by Western blotting (WB) using an anti-SPPrl antibody. SPPD/A–myc com-
plexes were detected with an anti-myc antibody (lane 5). The position of the 200kDa
SPPrl/SPPD/A-C200 complex and higher-molecular-mass SPP complexes are indicated.
(C) Afﬁnity puriﬁcation of SPPrl/SPP complexes. HEK-293 cells co-expressing pPrl and
SPPD/A–myc were lysed with 1% digitonin, and SPPD/A–myc complexes were afﬁnity-puriﬁed
on anti-myc beads. Aliquots of the total lysate, ﬂow-through (FT), wash fraction (wash) and
elutedfractions(eluate)werecharacterizedbyBN-PAGE(5–9%)andsilverstaining(lanes1–7)
or by Western blotting (WB) with an anti-myc antibody (lane 8) and an anti-SPPrl antibody (lane
9). Molecular masses are indicated in kDa.
The question arises as to what the features are that distinguish
proteins that bind to SPP from those that do not. A preprotein,
such as pPrl, accumulates because its signal sequence has not
been cleaved off by signal peptidase. It remains anchored in the
ER membrane via its signal sequence, resulting in a type II
oriented membrane protein. SPP co-expression enhances the
accumulationofpPrlandbothalsointeracttightlywitheachother.
The most likely explanation is that SPP is in close proximity
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Figure 7 Identiﬁcation of pPrl–SPP complexes
(A) Amino acid sequence of the signal sequence of wild-type pPrl and the mutant pPrlPP29,
which is not cleaved by signal peptidase (SPase) (both are C-terminally HA-tagged). The
V→Pmutation(PP29)isunderlined.h-regionsareindicatedwithadottedline.(B)Detectionof
matureprolactin(Prl),pPrlPP29 andSPPrl afterSDS/PAGEorBN-PAGE.HEK-293cellstransiently
expressingpPrl–HAorpPrlPP29–HAaloneortogetherwithSPP–mycorSPPD/A–mycwerelysed
with 1% digitonin, and total lysates were subjected to Tris/glycine SDS/PAGE (lanes 1–7) or
to BN-PAGE (6–16%; lanes 8–14). Mature prolactin (Prl–HA) and pPrl(PP29)–HA were identi-
ﬁedafterSDS/PAGEbyWesternblotting(WB)usinganti-HAantibodies,andSPPrl wasidentiﬁed
after BN-PAGE and Western blotting using anti-SPPrl antibodies. v, empty vector control. (C)
Identiﬁcation of pPrlPP29 in the 600kDa SPP complex after 2D-BN-SDS/PAGE. HEK-293 cells
transiently co-expressing pPrlPP29–HA and SPPD/A–myc were lysed with 1% digitonin, and
the total lysate was ﬁrst separated by BN-PAGE (6–13%) and then in the second dimension
by SDS/PAGE (12.5%). SPPD/A–myc complexes and pPrlPP29–HA were identiﬁed by Western
blotting (WB) using the anti-myc and the anti-HA antibody respectively. SPP dimers (di)
and pPrlPP29/SPP-C600 are indicated. The asterisk indicates a cross-reacting band. Molecular
masses are indicated in kDa.
to the translocation site in the ER membrane and optimally
placed to compete with signal peptidase for binding to the
signal sequence in the newly synthesized preprotein. Such an
SPP binding may then prevent signal peptidase from cleavage.
Consistent with this model, SPP is known to interact with the
translocon-associated protein TRAM1 (translocation-associated
membrane protein 1) [35]. A signal peptide and its parent
preprotein are only distinguished by the absence or presence of
the luminal ectodomain of the preprotein. Since mature prolactin
did not interact with SPP, it must be the signal sequence that
mediates the interaction with SPP. Although the preceding signal
sequence cleavage is required to allow SPP-mediated processing
of the signal peptide, as demonstrated previously [10], a luminal
ectodomain does not generally prevent an interaction with SPP.
Similarly, additional transmembrane domains, as in OP91H*, do
not prevent an SPP interaction.
In its overall topology, Ii resembles a preprotein that spans
the membrane with its signal anchor sequence. However, no
interaction between SPP and Ii has been detected. Since a luminal
domain, in principle, does not abolish an SPP interaction, there
may be intrinsic features in the transmembrane domain required
for SPP interaction. RAMP4 and a signal peptide are similar in
their overall topology. Both expose their N-terminal domains
inthecytosol,spanthemembranewiththeirhydrophobicdomains
and have a small C-terminal domain in the ER lumen. In contrast
with a signal peptide, RAMP4 does not interact with SPP. Taken
together, a type II topology and a small C-terminal domain in
the ER lumen are not sufﬁcient for an interaction with SPP, but
a large luminal domain, as well as additional transmembrane
domains, do not prevent an SPP interaction. It appears that
not one single and simple feature determines whether a protein
interacts with SPP. Since all proteins that interact with SPP have
a transmembrane domain, there might be intrinsic features in
this domain that are essential for an SPP interaction. Possibly the
structuralarrangementofthetransmembranedomainsdetermines
the accessibility to SPP. Truncated opsin proteins were shown to
have a less compact structure and a reduced α-helical content
compared with the correctly assembled wild-type opsin [36].
Thus misfolded proteins that are not correctly assembled may
expose their hydrophobic domains that are in turn accessible to
SPP. Similarly, preproteins are usually generated as by-products
of an inefﬁcient process, so that one can assume them to remain
unassembledanddestinedfordisposal.Incontrast,IiandRAMP4
are known to oligomerize with their physiological interaction
partners. Ii rapidly assembles into a homo-oligomeric complex
upon membrane insertion [37], whereas RAMP4 associates with
the Sec61 translocon and ribosomes [38]. Consequently, both
proteins are presumably not accessible to SPP and therefore
do not interact. In conclusion, we propose that the oligomeric
state of type II oriented membrane proteins may be one critical
determinant for their accessibility to SPP.
SPP assembles with substrates and client proteins into complexes
of different sizes
Using BN-PAGE, we identiﬁed endogenous and overexpressed
SPPs in three distinct high-molecular-mass complexes of 200,
400 and 600 kDa (C200, C400 and C600). A substrate, i.e. a
signal peptide, is trapped in SPP-C200 when SPP
D/A was co-
expressed, while its preprotein is predominantly found in SPP-
C600. In contrast, a misfolded membrane protein was identiﬁed
in all three SPP complexes.
Since the substrate is only detected in the SPP-C200 com-
plex, we suggest that this is the catalytically active SPP complex.
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Figure 8 Misfolded opsin accumulates in several SPP complexes
(A) Identiﬁcation of OP91H*–SPP complexes after BN-PAGE. HEK-293 cells transiently expressing OP91H* and SPP–myc or SPPD/A–myc as indicated were lysed with 1% digitonin, and aliquots
were separated by BN-PAGE (5–9%). OP91H* and SPP/SPPD/A–myc complexes were identiﬁed by Western blotting (WB) using anti-opsin and anti-myc antibodies respectively. SPP complexes of
200kDa (SPP-C200), 400kDa (SPP-C400) and 600kDa (SPP-C600) co-migrating with OP91H* are indicated. (B–D) Glycosylated and non-glycosylated opsin is found in complexes of the same
size. Digitonin lysates of HEK-293 cells transiently expressing OP91H* (B) or co-expressing SPP–myc (C) or SPPD/A–myc (D) were ﬁrst separated by BN-PAGE (6–13%) and then separated in the
seconddimensionbySDS/PAGE(15%).ToppanelsshowWesternblots(WB)oftheBNgelsusinganti-opsinantibodies.MiddlepanelsshowWesternblotsoftheupperpartofthesecond-dimension
SDSgelsusinganti-SPP antibodiesin(B)andanti-myc antibodiesin (C)and(D).Bottom panelsshowWestern blotsofthelowerpartofthesecond-dimensiongelusinganti-opsin antibodies.SPP
dimers (di) and non-, mono- (−1g) and bi- (−2g) glycosylated forms of OP91H* are indicated. Molecular masses are indicated in kDa.
Besides SPP, we did not ﬁnd any other protein in this complex,
consistent with the fact that SPP alone is sufﬁcient to process
signal peptides [1,18]. The 200 kDa complex is probably a dimer
of SPP-dimers, since we detect dimers after 2D-BN-SDS/PAGE
and since one SPP dimer has a molecular mass of approx. 90 kDa
[16]. In contrast, SPP client proteins accumulate predominantly
in the large SPP complexes C400 and C600. The presence of
these complexes correlates with the ﬁnding that the interacting
proteins are not substrates. As the amount of these complexes
was small after afﬁnity puriﬁcation, we could not identify their
protein constituents using MS. However, we found SPP dimers
using 2D-BN-SDS/PAGE and Western blotting, indicating that
this is the minimal SPP core in the large complexes. The higher
mass suggests that either SPP dimers homo-oligomerize into
larger complexes or that SPP dimers associate with further
proteins.
Taken together, our ﬁndings indicate that substrates and client
proteins can interact with SPP and are segregated by SPP. Both
SPP substrates and its clients may bind initially to a docking site
inSPP.Substratesmaythenentertheactivesiteandareprocessed,
whereas other proteins may be excluded from this site owing to
sterichindrancebytheirectodomains.Thismodelcouldapplyfor
a signal peptide and its preprotein. As the amino acid sequences
of the signal peptide and the signal sequence are identical, it
must be the large luminal ectodomain of the preprotein that
prevents processing [10,39]. Similarly, also misfolded polytopic
membrane proteins might be sterically hindered to enter the
active site as they contain more than one transmembrane domain.
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The model of distinct docking and active sites has previously
been deduced from the ﬁnding that a helical peptide inhibitor
binds to another SPP site than a transition-state analogue [40].
Moreover, this concept also implies that a signal peptide, which
entered the SPP active site, may be buried inside the protease. In
contrast, when a preprotein or a misfolded polytopic membrane
protein is bound to SPP, their additional domains, which are the
luminaldomainandthetransmembranedomainrespectively,may
stick out of the SPP molecule, enabling further interactions and
accumulation in larger SPP complexes. In these complexes, SPP
itself or additional cofactors could contribute accessory binding
sites. Since we identiﬁed all SPP complexes under steady-state
conditions after Western blotting, we do not know how they are
generated. It may be a dynamic process in which initially all SPP
interacting proteins bind the SPP-C200 homo-oligomer and then,
if not processed, mature into larger complexes. Alternatively, all
SPP complexes could pre-exist and recruit preferentially signal
peptides or unassembled membrane proteins with type II oriented
transmembrane domains.
Also for the SPP-like proteases SPPL2a and SPPL2b, an
interaction with substrates and the corresponding precursors
has been shown [41–43]. As observed for SPP, the precursors
interact with active SPPLs and accumulate. In contrast with
this, no interaction of precursors with presenilin as the catalytic
core of the γ-secretase complex has been observed so far
[44,45]. One explanation is that γ-secretase is a multi-protein
complex that consists of four subunits [19]. The catalytic
core subunit is presenilin, an aspartyl intramembrane protease
related to SPP, whereas a further subunit pre-selects peptide
substrates and transfers them to the docking site in presenilin
[46]. The characterization of γ-secretase by BN-PAGE identiﬁed
heterogeneous complexes ranging in size from 200 to 900 kDa,
but, in contrast with SPP, always included the subunits mentioned
[47,48].
In contrast with γ-secretase, SPP functions may be
characterized by a broad range of clients. Besides processing
of signal peptides, SPP may collect disposal-prone membrane
proteins. The interaction of SPP with clients that are prone to
disposal is consistent with the proposed role of SPP in ER quality
control of membrane proteins [14]. In such a scenario, SPP may
shield unassembled exposed transmembrane regions. The SPP
complexes we detect are possibly disposal-intermediates that
represent part of a platform at which proteins are dislocated from
theERmembrane[49].Infact,SPP-dependentproteindislocation
of full-length MHC class I heavy chains from the ER membrane
has been demonstrated previously in cells expressing the HCMV-
encoded immunoevasin US2 [15]. Furthermore, a recent study
demonstrates that SPP co-operates with the ubiquitin E3 ligase
TRC8 in the dislocation of MHC class I molecules from the ER
membrane [50].
ERAD includes substrate recognition, targeting to the
dislocation-machinery, dislocation from the ER membrane and
degradation of the substrate by the proteasome [51]. Misfolded
opsin proteins can be retained in the ER and can undergo
ER-associated degradation via the proteasome [34]. We have
shownthatOP91H*issubstantiallydegradedwhenoverexpressed
in cells. An interaction of misfolded opsin with endogenous
SPP has been demonstrated previously [14]. However, co-
expression of SPP impedes OP91H* degradation, resulting in
accumulation. This apparent discrepancy can be explained by
the overexpression situation. It is conceivable that high SPP
amounts result in a prolonged interaction with degradation
substrates, thereby impeding their efﬁcient degradation. We
attempted to clarify whether reduced SPP levels in the cell
may affect the degradation of misfolded proteins by employing
RNA interference. Substantial reduction of SPP did not lead to
impededdegradationofOP91H*(seeSupplementaryFigureS6at
http://www.BiochemJ.org/bj/427/bj4270523add.htm).Thiscould
mean that SPP is not necessary for the degradation of OP91H or
that low SPP amounts in the cell are sufﬁcient for SPP function.
In an alternative model, SPP may act in the collection of
disposal-prone membrane proteins by co-aggregating with them.
Misfolded membrane proteins that expose hydrophobic domains
tend to aggregate in the cell in an uncontrolled manner and can
even recruit correctly folded proteins into aggregates, which in
turn may lead to cell toxicity [34]. SPP with its ability to tightly
bind such membrane proteins and to assemble with them into
large oligomeric complexes, possibly aggregates, may contribute
to a controlled sequestering of toxic membrane protein species.
Large protein aggregates may then be eliminated by autophagic
mechanisms.
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Figure S1 Similar expression levels of SPP and SPPD/A
HEK-293 cells transiently expressing myc-tagged SPP or SPPD/A were lysed in the presence of
1%TritonX-100,andproteinswereseparatedbyTris/glycineSDS/PAGE.SPPmonomers(mo)
and dimers (di) were identiﬁed by Western blotting (WB) using the anti-myc antibody. v, empty
vector control. Molecular masses are indicated in kDa.
Figure S2 SPPrl and pPrl can be co-immunoprecipitated with an anti-myc
antibody, but not with an unrelated antibody
HEK-293 cells transiently expressing pPrl, SPP–myc or SPPD/A–myc were pulse labelled
for 30 min and chased for 1 h. Cells were lysed with 1% Triton X-100, and proteins were
immunoprecipitated (IP) with a monoclonal anti-myc antibody (left-hand panel) or with an
unrelated monoclonal antibody (right-hand panel). Proteins were separated on Tris/Tricine gels
and detected by autoradiography. SPP dimer (di) and monomer (mo) are indicated. v, empty
vector control. Molecular masses are indicated in kDa.
1 To whom correspondence should be addressed (email b.dobberstein@zmbh.uni-heidelberg.de).
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Figure S3 SPPrl does not accumulate or co-immunoprecipitate in the
presence of SPPL3D/A
HEK-293 cells transiently expressing pPrl, SPPL3–myc or SPPL3D/A–myc as indicated were
pulselabelledfor30min.Cellswerelysedwith1%TritonX-100,and1/10ofthetotallysatewas
analysed directly by SDS/PAGE, whereas the rest was used for immunoprecipitation (IP) using
either anti-SPPrl antibodies or anti-myc antibodies to identify myc-tagged SPPL3/SPPL3D/A.
Samples were subjected to Tris/Tricine SDS/PAGE, and labelled proteins were visualized by
autoradiography; v, empty vector control; Prl, mature prolactin. Molecular masses are indicated
in kDa.
Figure S4 The SPPrl/SPP complex is also stable in 1% Triton X-100 and 1%
DDM buffer
HEK-293 cells transiently expressing pPrl, SPP–myc or SPPD/A–myc were lysed with 1%
Triton X-100- (Tx) or 1% DDM-containing buffer, and an aliquot of total lysates was applied
to BN-PAGE (6–13%). SPP–myc and SPPrl were identiﬁed by Western blotting (WB) using
anti-myc and anti-SPPrl antibodies respectively. v, empty vector control. SPP complexes of 200
kDa (C200), 400 kDa (C400), 600 kDa (C600) and SPPrl are indicated. Molecular masses are
indicated in kDa.
Figure S5 Identiﬁcation of low amounts of OP91H*/SPP complexes after
BN-PAGEandWesternblottingusingananti-opsinantibody(longexposures)
A Western blot (WB) as shown in Figure 8(A) of the main text and probed with an anti-opsin
antibodywasexposedforaprolongedtimetovisualizefaintsignals.Opsincomplexesof200kDa
(C200), 400 kDa (C400) and 600 kDa (C600) are indicated. v, empty vector control. Molecular
masses are indicated in kDa.
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Figure S6 RNA interference-mediated SPP knockdown and the effects on OP91H* accumulation
HEK-293 cells were transiently transfected with 10 nM of either validated SPP-speciﬁc siRNA (small interfering RNA) (Silencer Select validated siRNA ID: s37580; Ambion) or a scrambled siRNA
(Silencer Select Control siRNA #1; Ambion). After 48 h, the cells were re-transfected with the respective siRNAs as indicated, together with plasmids encoding OP91H*. After an additional 48 h, cells
were either lysed in the presence of 1% digitonin and endogenous SPP amounts were identiﬁed by Western blotting (WB) using the anti-SPP antibody (A) or cells were pulse labelled for 10 min
and chased for various times as indicated (B). For Western blotting, lysates were mixed with SDS-sample buffer and heated to 37◦C for 10 min. Under these conditions, only the SPP dimer (di) was
detected after Western blotting. Upon transfection with SPP-speciﬁc siRNAs, endogenous SPP amounts were signiﬁcantly, but not completely, reduced( A, lane 2). After pulse–chase labelling of the
cells, proteins were immunoprecipitated (IP) using the anti-opsin antibody, and labelled protein was visualized by autoradiography. Non-, mono- (1g) and bi-glycosylated (2g) forms of OP91H*
are indicated (B). Molecular masses are indicated in kDa. (C) Quantiﬁcation of OP91H* amounts from two independent pulse–chase experiments. No signiﬁcant differences in the accumulation
of OP91H* upon SPP knockdown (B and C, middle panel) compared with cells which were transfected with scrambled siRNA (left-hand panel) or without transfection (right-hand panel), couldb e
detected during 6 h of chase.
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